Mostrar el registro sencillo del ítem

dc.contributor.authorGil Montoya, José Antonio 
dc.contributor.authorGerez-Muñoz, M.J.
dc.contributor.authorTriviño-Ibañez, Eva María
dc.contributor.authorCarrera Muñoz, Ismael
dc.contributor.authorBravo Pérez, Manuel 
dc.contributor.authorRashki, Mahsa
dc.contributor.authorSolís Urra, Patricio 
dc.contributor.authorEsteban Cornejo, Irene 
dc.contributor.authorGómez Río, Manuel 
dc.date.accessioned2025-12-05T07:43:28Z
dc.date.available2025-12-05T07:43:28Z
dc.date.issued2025-09
dc.identifier.citationGil-Montoya JA, Gerez-Muñoz MJ, Triviño-Ibáñez E, Carrera-Muñoz I, Bravo M, Rashki M, Solis-Urra P, Esteban-Cornejo I, Gómez-Río M. Periodontal disease and brain amyloid pathology in mild cognitive impairment. Neurologia (Engl Ed). 2025 Sep;40(7):641-650. doi: 10.1016/j.nrleng.2025.07.008es_ES
dc.identifier.urihttps://hdl.handle.net/10481/108602
dc.descriptionThe assessment of the cognitively healthy group was partially supported by the AGUEDA study (Ref: I+ D+ iRTI2018-095284-J-I00; 2018). For the remaining comparison groups, no specific grant was received from funding agencies in the public, commercial, or non-profit sectors.es_ES
dc.description.abstractIntroduction: Increases in brain -amyloid protein (A) levels have been demonstrated in animal models following oral inoculation of periodontopathogens or their enzyme gingipain. We investigated the association between periodontitis and brain A protein levels in mild cognitive impairment (MCI). Methods: An observational study was designed. All participants underwent a periodontal examination and an amyloid-PET scan. Subsequently, the following groups were established: MCI and suspected Alzheimer disease (AD) (MCI/A+ group) (n = 45); MCI and suspected non-AD pathology (MCI/A— group) (n = 59); cognitively healthy elderly individuals Results: Patients with moderate-severe periodontitis had a higher risk of abnormal accumulation of A in the brain, with an odds ratio (OR) of 3.30 (95% confidence interval [CI], 1.30—8.26) when comparing patients from the MCI/A+ and MCI/A— groups, and an OR of 4.94 (95% CI, 1.65—14.84) when comparing the MCI/A+ group against the non-MCI/A— group. Conclusions: Our findings suggest that periodontal disease may be associated with anomalous accumulation of cerebral A protein in older people, independently of cognitive impairment.es_ES
dc.description.sponsorshipAGUEDA study (Ref: I+ D+ iRTI2018-095284-J-I00; 2018)es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPeriodontal diseasees_ES
dc.subjectAlzheimer diseasees_ES
dc.subjectBeta-amyloides_ES
dc.subjectMild cognitive impairmentes_ES
dc.subjectAmyloid-PET scanes_ES
dc.titlePeriodontal disease and brain amyloid pathology in mild cognitive impairmentes_ES
dc.title.alternativeEnfermedad periodontal y afección cerebral amiloide en deterioro cognitivo levees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.nrleng.2025.07.008
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional